文献速递血管炎

在荷兰快速通道门诊中疑似巨细胞动脉炎患者中对2022年ACR/EULAR分类标准的外部验证

External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.
PubMed 文献 · RMD Open · 2023-01-01

在荷兰Twente医院集团早期巨细胞动脉炎(GCA)前瞻性队列中,对133例疑似GCA患者外部验证2022年ACR/EULAR分类标准,以随访6个月后风湿科医生临床诊断为参考标准。采用≥6分切点时曲线下面积(AUC)为0.96(95%CI 0.92至0.98),敏感度98.0%(95%CI 89.9%至100%),特异度57.5%(95%CI 45.9%至68.5%)。作者认为该标准AUC和敏感度极好、特异度中等,可能也可用于诊断目的但需谨慎解读。

要点

  • 133例疑似GCA患者中53例确诊GCA、80例未确诊,AUC为0.96(95%CI 0.92至0.98)。
  • 采用≥6分切点时敏感度98.0%(95%CI 89.9%至100%),特异度57.5%(95%CI 45.9%至68.5%)。
  • 多数被误分类的无GCA患者评分为6分和7分,因非GCA人群中临床和/或实验室标准常存在。

核心结论

  • 结果显示该分类标准用于GCA患者分类时AUC和敏感度极好、特异度中等。
  • 作者认为考虑到相关研究人群,新分类标准可能也可用于诊断目的,但需谨慎解读。

研究设计与样本

  • 研究纳入荷兰Twente医院集团早期GCA in Twente前瞻性队列中疑似GCA的患者。
  • 以随访6个月后由治疗风湿科医生验证的临床GCA诊断作为参考标准。
  • 按原始文献所述测试≥6分切点,计算受试者工作特征曲线下面积、敏感度和特异度。

主要发现

  • 共纳入133例疑似GCA患者,其中53例诊断为GCA,80例未诊断为GCA。
  • AUC为0.96(95%CI 0.92至0.98)。
  • 采用≥6分切点时敏感度为98.0%(95%CI 89.9%至100%),特异度为57.5%(95%CI 45.9%至68.5%)。
  • 多数被误分类的无GCA患者分类评分为6分和7分,因非GCA人群中临床和/或实验室标准常存在。

关键数值与推荐

  • 2022年ACR/EULAR巨细胞动脉炎分类标准,切点≥6分。
  • AUC 0.96(95%CI 0.92至0.98)。
  • 敏感度98.0%(95%CI 89.9%至100%),特异度57.5%(95%CI 45.9%至68.5%)。

临床怎么用

  • 作者认为该分类标准可能也可用于诊断目的,但需谨慎解读。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recently the Diagnostic and Classification Criteria in Vasculitis Study group developed and published new American College of Rheumatology/EULAR classification criteria for giant cell arteritis (GCA). To test robustness in a different clinical setting and inform clinicians on performance in clinical practice, we aim to externally validate them in patients with a suspicion of GCA referred to our GCA fast-track clinic. METHODS: Patients with suspected GCA from the Hospital Group Twente Early GCA in Twente prospective cohort were included. The clinical diagnosis of GCA verified after 6 months of follow-up made by the treating rheumatologist was used as a reference standard. A cut-off score of ≥6 was tested as described in the original article. Area under the receiver operating characteristics curve, sensitivity and specificity were calculated. RESULTS: In total, 133 patients with suspected GCA were included, of whom 53 were diagnosed with GCA and 80 patients were not diagnosed with GCA. The area under the curve (AUC) was 0.96 (95% CI 0.92 to 0.98). Using the proposed cut-off score of≥6, we found that sensitivity was 98.0% (95% CI 89.9% to 100%) and specificity was 57.5% (95% CI 45.9% to 68.5%). The majority of misclassified patients without GCA had classification scores of 6 and 7 as clinical and/or laboratory criteria were often present in our non-GCA population. CONCLUSION: Our results showed an excellent AUC and sensitivity with a moderate specificity for classification of GCA patients. Considering our relevant study population, we found that the new classification criteria might also be useful for diagnostic purposes, albeit with careful interpretation.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. van Nieuwland M, van Bon L, Vermeer M, et al. External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic. RMD Open. 2023. PMID: 37507207. doi:10.1136/rmdopen-2023-003080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。